Bb Biotech | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
Bb Biotech

BRIEF

published on 06/26/2024 at 14:13, 4 months 24 days ago

Edison Issues Report on BB Biotech (BION)

EQS Group Edison Report Financial Conduct Authority Investment Research BB Biotech
PRESS RELEASE

published on 06/26/2024 at 14:08, 4 months 25 days ago

Edison issues report on BB Biotech (BION)
Edison Investment Research issues report on BB Biotech (BION) in London, UK, on 26-Jun-2024. The report is available for free download on www.edisongroup.com. Contact enquiries@edisongroup.com for more information

Financial Analysis Edison Investment Research Report BB Biotech Investing
BRIEF

published on 05/20/2024 at 12:58, 6 months 1 day ago

Edison Issues Review on BB Biotech (BION): A Recovering Sector with a Healthy Prognosis

Investment Dividend Biotech Sector Market Outlook BB Biotech
PRESS RELEASE

published on 05/20/2024 at 12:53, 6 months 1 day ago

Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis
Edison issues review on BB Biotech (BION), highlighting its performance improvement and optimistic outlook in the recovering biotech sector, offering investors an opportunity for acquisition at an attractive level

Investors Edison Biotech Sector BB Biotech Review
BRIEF

published on 04/26/2024 at 07:05, 6 months 25 days ago

BB Biotech AG Announces Strong First Quarter Results in 2024 Interim Report

Financial Performance Net Profit BB Biotech AG Interim Report 2024 Biotechnology Investments
BRIEF

published on 04/26/2024 at 07:05, 6 months 25 days ago

BB Biotech Reports Strong First Quarter Amidst Biotech Market Uncertainties

Financial Results Biotechnology Healthcare Sector Investment Strategy BB Biotech
PRESS RELEASE

published on 04/26/2024 at 07:00, 6 months 25 days ago

EQS-Adhoc: BB Biotech AG publishes its interim report
BB Biotech AG publishes its interim report for the first quarter of 2024, revealing a net profit of CHF 260 million. The report includes details on the company's investment activities and performance

Investment Company Net Profit BB Biotech AG Interim Report Business Activities
PRESS RELEASE

published on 04/26/2024 at 07:00, 6 months 25 days ago

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
BB Biotech reports solid first-quarter results as interest rates impact biotech stock market. Net profit reaches CHF 260 mn. Key portfolio adjustments and milestones highlighted

Interest Rates First-quarter Results BB Biotech Biotech Stock Market Portfolio Adjustments
BRIEF

published on 03/21/2024 at 18:05, 7 months 30 days ago

BB Biotech AG's Shareholders Approve Dividend and Elect New Chairman

Board Of Directors Annual General Meeting Shareholders Dividend BB Biotech AG
PRESS RELEASE

published on 03/21/2024 at 18:00, 7 months 30 days ago

Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
Shareholders at BB Biotech AG's AGM approved a dividend of CHF 2.00 per share along with other proposals. Dr. Thomas von Planta elected as new Chairman

Shareholders Dividend AGM BB Biotech AG Dr. Thomas Von Planta

Accesswire

Published on 11/21/2024 at 13:30, 39 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 39 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 9 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 9 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 9 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 54 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 34 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 54 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 2 hours 2 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 2 hours 9 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 11 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 49 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 24 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 24 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE